IWAKI YUICHI — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
IWAKI YUICHI is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
Yuichi Iwaki is the President and Chief Executive Officer of MediciNova Inc., a biopharmaceutical company focused on small-molecule therapeutics for neurological disorders and fibrotic diseases. He is identified in the latest SEC filing for MediciNova (CIK 0001263965) dated 2026-01-20 as the company's President and CEO, indicating his leadership role in guiding the firm’s development portfolio, including MN-001, MN-166, and MN-221, with an emphasis on the U.S. market.
Role
President and CEO
Notability
40/100
Board memberships
MediciNova Inc (MNOV)
Awards & honors
Leading MediciNova's development strategy for MN-001, MN-166, MN-221
Overseeing focus on neurological disorders and fibrotic diseases
Frequently Asked Questions
Who is IWAKI YUICHI?
Yuichi Iwaki is the President and Chief Executive Officer of MediciNova Inc., a biopharmaceutical company focused on small-molecule therapeutics for neurological disorders and fibrotic diseases. He is identified in the latest SEC filing for MediciNova (CIK 0001263965) dated 2026-01-20 as the company's President and CEO, indicating his leadership role in guiding the firm’s devel…
Where can I see all of IWAKI YUICHI's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
